FDA Inspection
Samsung Biologics Co., Ltd.Samsung Biologics Co., Ltd. – FDA Inspection, Mar 14, 2018
Record Details
This FDA Inspection record concerns Samsung Biologics Co., Ltd., with an inspection on March 14, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Alicia M. Mozzachio (Issuing Officer)
- Thuy T. Nguyen (FDA Associated Person)
View Company Profile
ID · 2a781f9e-0bbf-467c-b957-087680264ad8
Inspection Facts
- Inspection number
- 1046813
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Samsung Biologics Co., Ltd.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 27, 2025 | Not classified | Office of Inspections and Investigations | |
| July 30, 2024 | Not classified | Office of Inspections and Investigations | |
| September 1, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Samsung Biologics Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.